---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-061039"
form_type: "8-K"
ticker: "AIDX"
cik: "0001139685"
company_name: "20/20 Biolabs, Inc."
filed_at: "2026-05-26T20:28:45+00:00"
generated_at: "2026-05-26T20:31:56.457376+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# 20/20 Biolabs reduces stockholder meeting quorum from majority to one-third

## Summary
- Board adopted Amendment No. 1 to Bylaws on May 19, 2026.
- Quorum required for stockholder meetings reduced from majority to one-third of outstanding shares.
- Amendment to Section 2.5 of Amended and Restated Bylaws; effective immediately.
- No other changes to stockholder rights or company governance structure.

## SEC filing metadata
- accession: 0001213900-26-061039
- form_type: 8-K
- ticker: AIDX
- cik: 0001139685
- company_name: 20/20 Biolabs, Inc.
- filed_at: 2026-05-26T20:28:45+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1139685/000121390026061039/0001213900-26-061039-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1139685/000121390026061039/ea0292180-8k_2020bio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-061039
- JSON: https://secwatch.observer/filing/0001213900-26-061039.json
- Plain text: https://secwatch.observer/filing/0001213900-26-061039.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.